Investigative Clinical Research of Indiana, LLC

18051 River Road
Suite 107
Noblesville, IN 46062
ph: 317-297-2208
fax: 317-297-1136
admin@investigativeicr.com

Clinical Trials - Hematology Oncology

The following is a comprehensive lists of our currently enrolling and ongoing trials.

Small Cell Lung Cancer and Squamous Non-Small Cell Lung Cancer
A phase 2, multicenter, open-label, multi-cohort study to assess safety and efficacy of CC-90011 in combination with Nivolumab in subjects with advanced cancers
Multiple Myeloma
An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen
Follicular Lymphoma and Marginal Zone Lymphoma
A Multicenter, Open-Label, Single-Arm, Phase 2 Study of Zandelisib(ME-401) in subjects with Follicular Lymphoma or Marginal ZoneLymphoma After Failure of Two or More Prior Systemic Therapies
Paroxysmal Nocturnal Hemoglobinuria
An open-label, nonrandomized, multicenter extention study to evaluate the long-term safety and efficacy of Pegcetacoplan in the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Melanoma
A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects with Melanoma Who Previoulsy Received Talimogene Laherparepve
Chronic Lymphocytic Leukemia
A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Myelofibrosis and Essential Thrombocythemia
Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy

18051 River Road
Suite 107
Noblesville, IN 46062
ph: 317-297-2208
fax: 317-297-1136
admin@investigativeicr.com